CASP3 and melanoma: The results revealed that hnRNP A2B1 silencing resulted in the decreased expression of the proliferation marker Ki-67 and the increased expression of caspase 3 compared with the control (Fig. 5i), indicating that the hnRNP A2B1 silencing triggered apoptosis of melanoma stem cells in vivo.